Ireland
--:--IST
Latest
Clinical Trials in France / NCT04781920
Recruiting Observational

Follow-up of Anterior Cruciate Ligament Reconstruction

NCT04781920 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2021-03-01
Last updated
2024-08-29

Condition(s) studied

Anterior Cruciate Ligament Rupture

Investigational drug(s) / intervention(s)

datas collection

datas collection: data collection in history medical : operative report, clinical examination, questionnaires, imaging, isokinetic tests

Study summary

Rupture of Anterior Cruciate Ligament (ACL) is a common pathology, but is subject to variability of associated lesions, surgical management and rehabilitation.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients having undergone an Anterior Cruciate Ligament (ACL) reconstruction Exclusion Criteria: * None

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Chu Saint-Etienne Saint-Etienne France Recruiting

More Centre Hospitalier Universitaire de Saint Etienne trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04781920 on ClinicalTrials.gov ↗ ← All trials in France